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Abstract
Background:  T lymphocytes are demonstrated to play an important role in several chronic pulmonary
inflammatory diseases. In this study we provide evidence that human lung fibroblasts are capable of mutually
interacting with T-lymphocytes leading to functionally significant responses by T-cells and fibroblasts.
Methods: Human lung fibroblast were co-cultured with PMA-ionomycin activated T-CD4 lymphocytes for 36
hours. Surface as well as intracellular proteins expression, relevant to fibroblasts and lymphocytes activation, were
evaluated by means of flow cytometry and RT-PCR. Proliferative responses of T lymphocytes to concanavalin A
were evaluated by the MTT assay.
Results: In lung fibroblasts, activated lymphocytes promote an increase of expression of cyclooxygenase-2 and
ICAM-1, expressed as mean fluorescence intensity (MFI), from 5.4 ± 0.9 and 0.7 ± 0.15 to 9.1 ± 1.5 and 38.6 ±
7.8, respectively. Fibroblasts, in turn, induce a significant reduction of transcription and protein expression of
CD69, LFA-1 and CD28 in activated lymphocytes and CD3 in resting lymphocytes. In activated T lymphocytes,
LFA-1, CD28 and CD69 expression was 16.6 ± 0.7, 18.9 ± 1.9 and 6.6 ± 1.3, respectively, and was significantly
reduced by fibroblasts to 9.4 ± 0.7, 9.4 ± 1.4 and 3.5 ± 1.0. CD3 expression in resting lymphocytes was 11.9 ±
1.4 and was significantly reduced by fibroblasts to 6.4 ± 1.1. Intracellular cytokines, TNF-alpha and IL-10, were
evaluated in T lymphocytes. Co-incubation with fibroblasts reduced the number of TNF-alpha positive
lymphocytes from 54,4% ± 6.12 to 30.8 ± 2.8, while IL-10 positive cells were unaffected. Finally, co-culture with
fibroblasts significantly reduced Con A proliferative response of T lymphocytes, measured as MTT absorbance,
from 0.24 ± 0.02 nm to 0.16 ± 0.02 nm. Interestingly, while the activation of fibroblasts is mediated by a soluble
factor, a cognate interaction ICAM-1 mediated was demonstrated to be responsible for the modulation of LFA-
1, CD28 and CD69.
Conclusion: Findings from this study suggest that fibroblasts play a role in the local regulation of the immune
response, being able to modulate effector functions of cells recruited into sites of inflammation.
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Introduction
Interactions between immunocompetent cells, such as
lymphocytes and monocytes/macrophages, and other
hematopoietic cell lineages is an essential and well known
feature of the immune and inflammatory response. Much
less attention has been given to the possibility of direct
and mutual interactions between immunocompetent
cells and resident cells such as fibroblasts. To this regard
we have previously shown that normal human lung
fibroblasts interact with monocytes suggesting their
involvement in the control of the immune and inflamma-
tory response [1,2]. In addition, we have demonstrated
that an impairment of fibroblast functions, as observed in
fibrotic fibroblasts, may lead to a reduced capability of
these cells to modulate monocyte activity [2]. Several data
indicate that in pulmonary chronic inflammatory dis-
eases, such as bronchial asthma and interstitial lung dis-
eases, lymphocytes are in an immunologically activated
state likely as the result of a persistent and excessive state
of immune activation, possibly due to a dysregulation of
the fine homeostatic balance governing the immune
response [3-5]. In this context, very limited attention has
been addressed to potential direct interactions between T
lymphocytes and lung fibroblasts [6,7]. Recent studies
have in fact provided evidence that the interaction
between lymphocytes and fibroblasts might be important
to the pathogenesis of chronic inflammatory diseases
such as periodontitis and rheumatoid arthritis. In perio-
dontitis, T lymphocytes are often found adjacent to gingi-
val fibroblasts [8] whereas in the inflammed synovium, T
lymphocytes and fibroblasts along with monocytes/mac-
rophages, represent the most abundant cell populations.
With regard to these disease conditions, it has been dem-
onstrated that T cells induce the activation of both gingi-
val and synovial fibroblasts [9,10]. In addition, it has
recently been shown that stromal cells are able to affect T-
cell apoptosis, contributing to the accumulation and/or
removal of these cells at sites of chronic inflammation
[11-13]. However, the inappropriate retention of T-cells
within the tissue is unlikely to be the only mechanism
leading to the switch from an acute resolving to a chronic
persistent inflammatory process and it is reasonable to
think that a persistent and excessive condition of immune
activation of these cells may be important as well. In view
of the above findings, that fibroblasts are capable of inter-
acting with T-lymphocytes, we set out to determine
whether the interaction between normal human lung
fibroblasts and T-cells could lead to a functionally signifi-
cant response by T-lymphocytes, influencing their state of
immune activation. Our results indicate that lung fibrob-
lasts and T-lymphocytes indeed mutually interact. Acti-
vated lymphocytes induce the expression of
cyclooxygenase-2 (COX-2) and dramatically increase the
expression of intercellular adhesion molecule-1 (ICAM-1)
in normal human lung fibroblasts. Fibroblasts, in turn,
induce a significant reduction of transcription and protein
expression of CD69, considered as a marker of early T cell
activation, lymphocyte function associated antigen-1
(LFA-1), CD3 and CD28, all molecules involved in T-lym-
phocyte activation and costimulation [14-16].
According to this phenotypic down-regulation, lym-
phocytes co-cultured with fibroblasts, show a significant
reduction of the production of tumor necrosis factor-α
(TNFα), while the production of interleukin-10 (IL-10) is
not affected. This condition of reduced activation is fur-
ther underlined by a reduced proliferation of lymphocytes
co-cultured with fibroblasts in response to a mitogenic
stimulus.
It is interesting to note that while the activation of fibrob-
lasts is mediated by a soluble factor, a cognate interaction
between ICAM-1 and LFA-1 is responsible for the modu-
lation of LFA-1, CD28 and CD69 on T-cells.
These data confirm and expand the concept that human
lung fibroblasts may actively interact with immune cells
affecting a large array of functions strictly related to the
control and regulation of the local immune response.
Materials and methods
Lung Fibroblasts
Seven primary lines of normal human adult lung fibrob-
lasts were established by using an outgrowth from explant
according to the method described by Jordana and cow-
orkers [17]. Fibroblast lines were derived from histologi-
cally normal areas of surgical lung specimens from
patients undergoing resective surgery for cancer. Their
ages ranged from 52 to 61 yr. Five of six patients were
men. Lung specimens were chopped into pieces of less
than 1 mm3 and washed once with PBS and twice with
RPMI-1640 containing 10% FCS, penicillin 100 U/ml,
streptomycin 100 mcg/ml, and fungizone 25 mcg/ml
(supplemented RPMI) (Gibco, Paisley, UK); eight to ten
pieces of washed specimens were then plated in a 100-
mm polystyrene dish (Falcon, Becton Dickinson, Lincoln
Park, NJ, USA) and overlaid with a coverslip held to the
dish with sterile vaseline. Ten milliliters of supplemented
RPMI were added and the tissue was incubated at 37°C
with 5% CO2. The medium was changed weekly. When a
monolayer of fibroblast-like cells covered the bottom of
the dish, usually 5 to 6 weeks later, the explant tissue was
removed, and the cells were then trypsinized for ten min-
utes, resuspended in 10 ml of supplemented RPMI, and
plated in 100-mm tissue culture dishes. Subsequently,
cells were split 1:2 at confluence, usually weekly. Aliquots
of cells were frozen and stored in liquid nitrogen. In all
experiments we used cell lines at a passage earlier than the
tenth.Respiratory Research 2005, 6:103 http://respiratory-research.com/content/6/1/103
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Lymphocyte isolation procedure
Heparinized venous blood, obtained from healthy
donors, was diluted 1:3 with PBS, and 40 ml were then
placed on 10 ml of Lymphoprep (Axis-Shield, Oslo, Nor-
way) for centrifugation at 1,600 rpm for 35 minutes at
room temperature. Mononuclear cells were collected at
the interface, washed three times and resuspended in PBS
supplemented with 0.5% bovine serum albumin and 2
mM EDTA. Isolation of human CD4 lymphocytes from
mononuclear cells was performed by positive selection of
CD4+ cells using a magnetic cell sorting system (MACS,
Miltenyi Biotec, Bergisch Gladbach, Germany) according
to manufacturer's instructions. Mononuclear cells were
magnetically labeled with CD4 microbeads and passed
through a separation column placed in the magnetic field
of the MACS separator. The magnetically labeled cells
were retained in the column while the unlabeled cells run
through. After removal of the column from the magnetic
field labeled cells, representing the enriched CD4+ cell
fraction, passed through the column and were collected as
effluent.
Lymphocyte-Fibroblast Co-cultures
Lymphocytes were incubated in 60 mm polystyrene dish
(Falcon, Becton-Dickinson) at a concentration of 4 × 106
cells in 4 ml of supplemented RPMI in the absence or
presence of 1 µg/ml of ionomycin and 10 ng/ml of PMA,
plates were then incubated in a humidified atmosphere of
5% CO2 at 37°C. After 6 hours cells were harvested,
washed three times with PBS and counted. 1 × 106 lym-
phocytes were then seeded on top of 0.5 × 106 fibroblasts
in 6-well tissue culture plates in a final volume of 2 ml of
supplemented RPMI and incubated for 36 hours. After the
36 hours of co-culture fibroblasts were adherent to the
dish and maintained the typical spindle shaped aspect.
Lymphocyte viability was assessed by the trypan blue
exclusion method that constantly gave a >90% survival. In
some experiments cells were separated by a semiper-
meable membrane (0.4 mcm pores) using a cell culture
insert (Falcon, Becton Dickinson). In blocking experi-
ments fibroblasts were pretreated with a blocking anti-
ICAM antibody (Calbiochem Corporation, San Diego,
CA, USA) for 2 hours before the addition of the lym-
phocytes and once again when the co-culture started.
RNA Isolation and Reverse Transcriptase-Polymerase 
Chain Reaction
Total cellular RNA was extracted from cells with the gua-
nidium isothiocyanate/acid-phenol procedure as previ-
ously described [18]. The yield and the purity of RNA was
measured spectrophotometrically by absorption at 260/
280 nm. Total RNA was used for the generation of cDNA.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
was performed using the SuperScript™ First-Strand Syn-
thesis System for RT-PCR (Invitrogen Inc., Paisley, UK),
with some modifications. Briefly, 5 µg of total RNA was
reverse transcribed with 50 U of RNase OUT Recombinant
(Superscript™ II RT, Invitrogen). The reverse-transcribed
product (cDNA) was amplified by PCR (Perkin Elmer
Gene Amp PCR System 2400) in the presence of a master
mix containing PCR buffer, MgCl2 (under optimal con-
centrations), 1 U Taq DNA Polymerase Recombinant
(Invitrogen), 10 mM dNTPs. The following specific
primer pairs were used: ICAM-1 sense 5'-GAGCTGTTTGA-
GAACACCTC-3' and antisense 5'-TCACACTTCACTGT-
CACCTC-3' giving a 367 bp PCR product; COX-2 sense 5'-
TTCAAATGAGATTGTGGGAAAATTGCT-3' and antisense
5'-AGATCATCTCTGCCTGAGTATCTT-3' (305 bp prod-
uct); LFA-1 sense 5'-GTCCTCTGCTGAGCTTTACA-3' and
antisense 5'-ATCCTTCATCCTTCCAGCAC-3' (337 bp
product); CD-28 sense 5'-AAGTTGAGAGCCAAGAGCAG-
3' and antisense 5'-CCGACTATTTTTCAGTGACA-3' (304
bp product); CD-69 sense 5' CCTTCCAAGTTCCTGTCC-3'
and antisense 5' CATTCCATGCTGCTGACCTC-3' (451 bp
product); CD-3 sense 5' GTGTCATTCTCACTGCCTTGT-
TCC-3' and antisense 5'-TTCAGTGGCTGAGAAGAGT-
GAACC-3' (496 bp product); beta-actin sense 5'-
TGACGGGGTCACCCACACTGTGCCCATCTA-3' and
antisense 5'-CTAGAAGCATTGCGGTGGACGAT-
GGAGGG-3' (661 bp product). PCR was performed for 40
cycles, using a cycling program of 94°C for 5 min, 55°C
for 59 sec and 72°C for 59 sec in a thermal cycler for the
amplification of ICAM-1 and COX-2, for the amplifica-
tion of LFA-1 and CD-28, PCR was performed for 35
cycles, using a cycling program of 94°C for 5 min, 54°C
for 59 sec and 72°C for 59 sec, while for the amplification
of CD-69 and CD-3 PCR was performed for 25 and 30
cycles, using a cycling program of 94°C for 5 min, 52°C
and 57°C for 59 sec and 72°C for 59 sec, respectively.
Final extension was at 72°C for 7 min for all molecules.
PCR-amplified products (10 µl) were electrophoresed
through a 1,8% agarose gel (Ambion Inc., Austin, Tx,
USA) containing 0,5 µg/ml of ethidium bromide and
compared with DNA reference markers. Products were vis-
ualized by ultraviolet illuminations. Polaroid photo-
graphs with ultraviolet exposure were taken with a 665
Polaroid film. Bands were analyzed with the Phoretix 1D
version 3.0.
Flow cytometric analysis
Experiments to determine ICAM-1 and COX-2 expression
on fibroblasts and LFA-1, CD3, CD28 and CD69 expres-
sion on lymphocytes were carried out on cells isolated and
co-cultured as described before. After 36 hours of co-col-
ture cells were lightly trypsinized, washed and resus-
pended in PBS with 0.1% BSA. The cells were incubated
with primary antibodies, anti-LFA-1 mAb (Dako Italia,
Milan, Italy), anti-CD3 and anti-CD69 mAbs (Beckman
Coulter Italia, Milan, Italy), or anti-COX-2 policlonal Ab
(Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) forRespiratory Research 2005, 6:103 http://respiratory-research.com/content/6/1/103
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60 min at room temperature. Following washing, the sec-
ondary antibody, fluorescein (FITC)-conjugated rabbit
anti-mouse IgG, was added for 60 min at room tempera-
ture. Controls included omission of the primary antibody
and incubation only with the secondary antibody. For
COX-2 detection cells were in advance permeabilized
with Triton 10x for 5 min at 4°C. FITC-labeled anti-ICAM-
1 (Dako Italia) and PE-labeled anti-CD28 (BD Pharmin-
gen Italia, Milan, Italy) were also used. Samples were ana-
lyzed using a Coulter Epics Elite ESP flow cytometer
(Coulter Corporation, Miami, FL, USA). Fibroblasts and
lymphocytes were gated on the basis of forward and side
scatter profile. Intracellular staining of cytokines was per-
formed using a method originally developed by Laskay
and Anderson [19] and recently modified by Assenmacher
et al. [20]. Briefly, Brefeldin A at 10 µg/mL (Sigma-Aldrich
Co., St Louis, MO, USA), was added to cultures and cocul-
tures CD4+ T cells and fibroblasts described above, for the
final 5 hours of our experimental setup. Cells were then
harvested and washed once in PBS. Freshly prepared for-
maldehyde solution (2% in PBS) was added to the cell
pellet. Cells were vigorously resuspended and fixed for 20
minutes at room temperature. After washing in saponin
buffer (0.5% saponin and 1% BSA in PBS) (Sigma-Aldrich
Co., St Louis, MO, USA) the cells were stained, for 1 hour
in the dark, in 100 mcl of saponin buffer containing FITC-
or PE-conjugated anti-cytokine antibody at the following
concentrations: anti-IL10-PE (2.5 µg/ml), anti-IFNγ-PE
Representative flow cytometry histograms of ICAM-1 (a) and COX-2 (b) in fibroblast alone (FA), fibroblasts co-cultured with  PMA-stimulated lymphocytes (FA+LPMA) Figure 1
Representative flow cytometry histograms of ICAM-1 (a) and COX-2 (b) in fibroblast alone (FA), fibroblasts co-cultured with 
PMA-stimulated lymphocytes (FA+LPMA). ICAM-1 (c) and COX-2 (d) expression in fibroblasts, fibroblasts co-cultured with 
PMA-stimulated lymphocytes, fibroblasts co-cultured with PMA-stimulated lymphocytes in the presence of a semipermeable 
membrane (FA+LPMA ins.) Data represent means ± SE of seven independent experiments in which seven different cells lines 
were used.
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(2.5 µg/ml), anti-TNFalpha-PE (2.5 µg/ml), anti-IL4-FITC
(5 µg/ml) (Caltag Laboratories, Burlinghame, CA, USA).
Thereafter, the cells were washed three times with saponin
buffer, once with PBS and analyzed by flow cytometry.
Gating was always restricted on T cells. Therefore, all
depicted data are given in percent of CD4+ T cells. Control
stainings with PE- or FITC-coupled isotype-matched anti-
body were performed in preliminary experiment and
never stained >0.3% of CD4+ T cells.
At least 10,000 forward and side scatter gated events were
collected per specimen. Cells were excited at 488 nm and
the fluorescence was monitored at 525 nm. Fluorescences
were collected using logarithmic amplification.
Lymphocytes proliferation assay
After 36 hours co-culture protocol CD4+ lymphocytes
were harvested and plated at a density of 2.5 × 105 cells in
24 well plates in supplemented RPMI with 2,5 mcg/ml
Concanavalin A (Con A, Sigma-Aldrich Co.) and incu-
bated for 72 hours at 37°C in a 5% CO2 atmosphere, lym-
phocytes co-cultured with fibroblasts were very gently
harvested with warm PBS to detach them from the fibrob-
lasts monolayer, CD4+ T cells harvested this way, had
always more than 95% of purity as assessed by differential
cell counts and by flow cytometry. Thereafter medium was
removed, cells were incubated with fresh medium con-
taining 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) (Sigma-Aldrich Co.) at a final
concentration of 0.9 mg/ml for 2 h at 37°C. The solubili-
zation solution, containing acidified isopropanol and
20% SDS, was added and left for 20 min in order to extract
the produced formazan which was then evaluated in a
plate reader (absorbance = 560 nm).
Statistical analysis
Statistical comparisons of the levels of expression of
ICAM-1, COX-2, LFA-1, CD3, CD28, CD69, IL10 and
TNF-alpha in all different experimental conditions were
performed using a two-way analysis of variance (ANOVA)
followed by the Newman-Keuls test for comparisons of
specific means, the same tests were used to assess differ-
ences among T cells proliferative responses to Con A. A p
value of less than 0.05 was considered significant. Results
are expressed as mean ± SE.
Results
Cultured lung fibroblasts, under basal conditions,
expressed both ICAM-1 and COX-2 as measured by mean
fluorescence intensity (MFI) of positive cells at flow cyto-
metric analysis. Exposure of fibroblasts to resting lym-
phocytes produced an increased expression of both ICAM-
1 (from 0.7 ± 0.4 to 2.5 ± 1.4) and COX-2 (from 5.4 ± 0.9
to 6.8 ± 1.1) that however did not yield statistical signifi-
cance. In contrast, co-incubation of fibroblasts with acti-
vated lymphocytes determined a pronounced increase of
the expression of both ICAM-1 and COX-2 MFI to 38.6 ±
7.8 (P < 0.001) and 9.1 ± 1.5 (P < 0.001), (Fig. 1a–d). This
effect was fully preserved when the two cell types were
maintained physically separated by a semi-permeable
membrane. The ability of activated lymphocytes to affect
ICAM-1 and COX-2 expression was likely exerted at the
transcriptional level as suggested by RT-PCR that revealed
increased ICAM-1 and COX-2 transcripts in fibroblasts
incubated with activated lymphocytes for 36 h (Fig 2a,b).
Again, the increased expression was maintained in the
presence of a separating semi-permeable membrane.
Levels of mRNA for ICAM-1 (a) and COX-2 (b) in fibroblasts  (FA), fibroblasts co-cultured with PMA-stimulated lym- phocytes (FA+LPMA), fibroblasts co-cultured with PMA- stimulated lymphocytes in the presence of a semipermeable  membrane (FA+LPMA ins.) Figure 2
Levels of mRNA for ICAM-1 (a) and COX-2 (b) in fibroblasts 
(FA), fibroblasts co-cultured with PMA-stimulated lym-
phocytes (FA+LPMA), fibroblasts co-cultured with PMA-
stimulated lymphocytes in the presence of a semipermeable 
membrane (FA+LPMA ins.). In the upper panels, modifica-
tions in the appearance of a 367-bp (ICAM-1) and a 305-bp 
(COX-2) band are compared with that of a β-actin. In the 
lower panels, the densitometric analysis is shown. Data are 
from one experiment representative of three.
0,0
0,4
0,8
1,2
1,6
FA FA+LPMA FA+LPMA ins.
β β β β-actina
ICAM-1
COX 2
β β β β-actina
I
C
A
M
-
1
/
β
-
a
c
t
i
n
a
C
O
X
2
/
β
-
a
c
t
i
n
a
a
b
0,0
0,5
1,0
1,5
FA FA+LPMA FA+LPMA ins.Respiratory Research 2005, 6:103 http://respiratory-research.com/content/6/1/103
Page 6 of 13
(page number not for citation purposes)
Expression of LFA-1, CD28 and CD69 in lymphocytes was
markedly increased by exposure to 10 ng/ml PMA for 6 h,
from 8.4 ± 0.5 for LFA-1, 6.9 ± 0.4 for CD28 and 2.6 ± 0.6
for CD69 to 16.6 ± 0.7 (P < 0.001), 18.9 ± 1.9 (P < 0.001)
and 6.6 ± 1.3 (P < 0.01), respectively (Fig. 3a–f). However,
co-incubation of activated lymphocytes with fibroblasts,
significantly reduced the expression of LFA-1, CD28 and
CD69 to 9.4 ± 0.7 for LFA-1 (P < 0.001), 9.4 ± 1.4 for
CD28 (P < 0.001) and 3.5 ± 1.0 (P < 0.05) for CD69, an
effect that required the physical contact between the two
cell types, as suggested by the fact that it was not present
any more when a semi-permeable membrane was applied
(Fig. 3b,d,f). In this condition, MFI was 16.5 ± 0.6 for LFA-
1, 18.4 ± 1.9 for CD28 and 7.1 ± 1.8 for CD69, all these
values being statistically increased compared to cells cul-
tured without the membrane (P < 0.01) and not signifi-
cantly different to those observed in activated
lymphocytes cultured in absence of fibroblasts. RT-PCR
revealed that the reduced expression of LFA-1, CD28 and
CD69 was related to their decreased transcription (Fig.
4a–c) and, similarly to what observed with protein expres-
sion, the reducing effect of fibroblasts was prevented by
the presence of a membrane between the two cell types
(Fig. 4a–c).
Representative flow cytometry histograms of LFA-1 (a), CD28 (c) and CD69 (e) in PMA-stimulated lymphocytes (LPMA),  PMA-stimulated lymphocytes co-cultured with fibroblasts (LPMA+FA) Figure 3
Representative flow cytometry histograms of LFA-1 (a), CD28 (c) and CD69 (e) in PMA-stimulated lymphocytes (LPMA), 
PMA-stimulated lymphocytes co-cultured with fibroblasts (LPMA+FA). LFA-1 (b), CD28 (d) and CD69 (f) expression in resting 
lymphocytes (LA), PMA-stimulated lymphocytes, PMA-stimulated lymphocytes co-cultured with fibroblasts and PMA-stimu-
lated lymphocytes co-cultured with fibroblasts in the presence of a semipermeable membrane (LPMA+FA ins.). Data represent 
means ± SE of seven independent experiments in which seven different cells lines were used.
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To ascertain whether the reduced protein expression
could be ascribed to activation of ICAM-1 on lymphocyte
surface, the same experiment was performed in the pres-
ence of a blocking anti-ICAM-1 antibody. Under these
conditions, lymphocyte expression of LFA-1, CD28 and
CD69 was fully restored, being statistically increased com-
pared to cells cultured with fibroblasts and not signifi-
cantly different to those observed in activated
lymphocytes (Fig. 5a–c).
Expression of CD3 was evaluated in resting lymphocytes
as activation by PMA did not significantly modify expres-
sion of the protein. Co-incubation of resting lymphocytes
with fibroblasts significantly reduced CD3 expression
both at translational (Fig. 6a,b) and transcriptional (Fig.
6c) level, an effect that was completely prevented in the
presence of a separating membrane. Indeed, CD3 MFI was
reduced from 11.9 ± 1.4 to 6.4 ± 1.1 (P < 0.001), while in
experiments performed with a separating membrane,
CD3 MFI was restored to (11.0 ± 0.9) (P < 0.001).
Finally, in order to evaluate whether the interaction
between fibroblasts and lymphocytes could give rise to
changes of the function of the latter cell population, two
different approaches were used. As a first step, lym-
phocytes exposed to fibroblasts were tested for their intra-
cellular production of cytokines. Attention has been
Levels of mRNA for LFA-1 (a), CD28 (b) and CD69 (c) in  resting lymphocytes (LA), PMA-stimulated lymphocytes  (LPMA), PMA-stimulated lymphocytes co-cultured with  fibroblasts (LPMA+FA) and PMA-stimulated lymphocytes co- cultured with fibroblasts in the presence of a semipermeable  membrane (LPMA+FA ins.) Figure 4
Levels of mRNA for LFA-1 (a), CD28 (b) and CD69 (c) in 
resting lymphocytes (LA), PMA-stimulated lymphocytes 
(LPMA), PMA-stimulated lymphocytes co-cultured with 
fibroblasts (LPMA+FA) and PMA-stimulated lymphocytes co-
cultured with fibroblasts in the presence of a semipermeable 
membrane (LPMA+FA ins.). In the upper panels, modifica-
tions in the appearance of a 337-bp (LFA-1), a 304-bp 
(CD28) and a 451-bp (CD69) band are compared with that 
of a β-actin. In the lower panels, the densitometric analysis is 
shown. Data are from one experiment representative of 
three.
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cultured with fibroblasts (LPMA+FA) and PMA-stimulated 
lymphocytes co-cultured with fibroblasts in the presence of 
an anti ICAM-1 blocking antibody (LPMA+FA+anti ICAM-1). 
Data represent means ± SE of four independent 
experiments.
a
b
c
LPMA FA + LPMA FA+LPMA+Anti-ICAM-1
0
10
20
C
D
2
8
M
F
I
LPMA FA + LPMA FA+LPMA+Anti-ICAM-1
0
1
2
3
4
5
6
7
C
D
6
9
M
F
I
p=NS
p<0.01 p<0.001
p=NS
p<0.001 p<0.001
p=NS
p<0.05 p<0.05
LPMA FA + LPMA FA+LPMA+Anti-ICAM-1
0
10
20
L
F
A
-
1
M
F
IRespiratory Research 2005, 6:103 http://respiratory-research.com/content/6/1/103
Page 8 of 13
(page number not for citation purposes)
focused on TNF-alpha and IL-10, two cytokines whose
role in lymphocyte function has been thoroughly charac-
terized. As expected, an increase of both TNF-alpha (from
2.5% ± 5.4 to 54.4% ± 6.12, p < 0.01) and IL-10 (from
15.8% ± 5.2 to 53.3% ± 4.6, p < 0.01) positive cells was
observed following activation with PMA, (Fig. 7b). Inter-
estingly, co-incubation with fibroblasts significantly
reduced the number of TNF-alpha positive lymphocytes
(from 54.4% ± 6.12 to 30.8% ± 2.8, p < 0.05), without any
significant change of IL-10 positive cells (from 53.3% ±
4.6 to 54.9% ± 5.9, p = NS). Finally we tested the ability
of concanavalin A to induce a proliferative response in
activated lymphocytes. This proliferation was partially
quenched in lymphocytes co-cultured with fibroblasts
(Fig. 8). Indeed, proliferation measured as MTT absorb-
ance was reduced from 0.24 nm ± 0.02 of activated
lymphocytes to 0.15 nm ± 0.04, p < 0.05, an effect fully
maintained when a semi-permeable membrane was
applied (0.16 nm ± 0.02, p < 0.01).
Discussion
A great deal of evidence is today available showing that
resident cells such as fibroblasts, through the release of
soluble signals and/or direct interactions with other cells,
may serve as potential regulators of the local inflamma-
tory response [21]. Based on our previous findings,
human lung fibroblasts, through the modulation of some
monocyte activities, may also participate in the control of
the immune response [1]. We have shown that normal
human lung fibroblasts are able to interact with mono-
cytes, driving the release of cytokines, whose role is crucial
in the regulation of the immune response, i.e. they
strongly stimulate interleukin 10 (IL-10) production by
LPS-activated monocytes and inhibit interleukin 12 (IL-
12). The increase of IL-10 production, induced by
fibroblasts, is able, in an autocrine way, to downregulate
the expression of human leukocyte-associated antigen-DR
(HLA-DR) as well as the expression of CD40 on mono-
cytes, potentially affecting the antigen presenting capacity
of these cells as well as their costimulatory function. In
addition, we have also shown that an impairment of
fibroblast functions, as observed in fibrotic fibroblasts,
may lead to a reduced capability of these cells to modulate
monocyte activity [1].
In view of the above mentioned experimental evidence we
set out to determine whether the interaction between nor-
mal human lung fibroblasts and immune cells such as T-
lymphocytes could lead to a functionally significant
response by these cells.
Several lung diseases, including hypersensitivity pneumo-
nitis, sarcoidosis and bronchial asthma are in fact charac-
terized by an involvement of T-lymphocytes and a
subsequent impairment of the immune and
inflammatory response [3,22-24]. Another element, com-
mon to these diseases, is represented by the possibility
that the inflammatory state may ultimately lead to
fibroblast activation and tissue fibrosis. Indeed, intersti-
(a) Representative flow cytometry histogram of CD3 in rest- ing lymphocytes (LA) and in resting lymphocytes co-cultured  with fibroblasts (LA+FA) Figure 6
(a) Representative flow cytometry histogram of CD3 in rest-
ing lymphocytes (LA) and in resting lymphocytes co-cultured 
with fibroblasts (LA+FA). (b) CD3 expression in resting lym-
phocytes, resting lymphocytes co-cultured with fibroblasts 
and resting lymphocytes co-cultured with fibroblasts in the 
presence of a semipermeable membrane (LA+FA ins.). Data 
represent means ± SE of seven independent experiments in 
which seven different cells lines were used. (c) Levels of 
mRNA for CD3 in resting lymphocytes, resting lymphocytes 
co-cultured with fibroblasts and resting lymphocytes co-cul-
tured with fibroblasts in the presence of a semipermeable 
membrane. In the upper panel, modifications in the appear-
ance of a 496-bp (CD3) band are compared with that of a β-
actin. In the lower panel, the densitometric analysis is shown. 
Data are from one experiment representative of three.
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tial lung diseases are marked by fibrosis and also bron-
chial asthma is characterized by an extensive remodeling
of the bronchial wall due to fibroblast activation and col-
lagen deposition [25-27].
Our results indicate that lung fibroblasts and T-lym-
phocytes mutually interact. Activated lymphocytes induce
COX-2 mRNA accumulation and protein expression and
dramatically increase both transcription and expression of
ICAM-1 in normal human lung fibroblasts. Fibroblasts, in
turn, induce a significant reduction of transcription and
protein expression of CD69, a marker of early T activation,
and LFA-1, CD3 and CD28, all molecules involved in T-
lymphocyte activation and costimulation. Moreover,
TNF-alpha a typical proinflammatory cytokine [28], was
significantly inhibited by fibroblasts, whereas IL-10, com-
monly considered as a regulatory cytokine [29] was not
affected by fibroblasts. Finally, we have demonstrated that
lymphocytes co-cultured with fibroblasts show a signifi-
cantly reduced proliferative response to a mitogenic
stimulus.
The enhanced expression of both COX-2 and ICAM-1 on
fibroblasts, induced by activated lymphocytes, was not
affected by the presence of a semi-permeable membrane
separating fibroblasts and lymphocytes, suggesting that
(a) Representative flow cytometry dot plots of TNF-α and IL-10 positive PMA-stimulated lymphocytes (LPMA) and PMA-stim- ulated lymphocytes co-cultured with fibroblasts (LPMA+FA) Figure 7
(a) Representative flow cytometry dot plots of TNF-α and IL-10 positive PMA-stimulated lymphocytes (LPMA) and PMA-stim-
ulated lymphocytes co-cultured with fibroblasts (LPMA+FA). (b) TNF-α and IL-10 positive cells, expressed as percentage, 
among resting lymphocytes (LA), PMA-stimulated lymphocytes and PMA-stimulated lymphocytes co-cultured with fibroblasts. 
Data represent means ± SE of 4 independent experiments.
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the T cell-induced fibroblast activation is likely mediated
by soluble factors produced by lymphocytes. The
increased expression of COX-2 induced by T cells on
fibroblasts is of great interest considering that a large
number of studies depicts COX-2 and its products, pros-
taglandins, as a major pathway occurring in the lung dur-
ing the control and self-limitation of the inflammatory
and reparative process [30]. As regard as the increased
expression of ICAM-1 on fibroblasts cocultured with lym-
phocytes, it has already been shown that various cytokines
produced by mononuclear cells enhance adhesiveness of
fibroblasts for T cells, through up-regulation of fibroblast
ICAM-1 expression, promoting T cell retention, position-
ing and accumulation in the tissues [31,32]. This observa-
tion suggests that T cells, once migrated into the tissue,
facilitate their own retention by boosting local fibroblast
adhesive properties. This event is commonly considered
important for the persistence of inflammation and block-
ade of the interaction between resident cells and T cells
may eventually down-regulate inflammation, represent-
ing an ideal target for disrupting immune-non-immune
cell interaction. To this regard, in different animal experi-
mental models attenuation of inflammation and reduc-
tion in collagen deposition have been described when
neutralizing antibodies against adhesion molecules are
used [33,34]. However, in an ICAM-1 knockout mice, ble-
omycin has been reported to induce a more severe pulmo-
nary fibrosis compared to their wild-type counterparts
Proliferative responses of resting lymphocytes (LA), PMA-stimulated lymphocytes (LPMA), PMA-stimulated lymphocytes co- cultured with fibroblasts (LPMA+FA) and PMA-stimulated lymphocytes co-cultured with fibroblasts in the presence of a semi- permeable membrane (LPMA+FA ins.), measured by means of MTT, after 72 hours culture in the presence of 2,5 µg/ml conca- navalin A Figure 8
Proliferative responses of resting lymphocytes (LA), PMA-stimulated lymphocytes (LPMA), PMA-stimulated lymphocytes co-
cultured with fibroblasts (LPMA+FA) and PMA-stimulated lymphocytes co-cultured with fibroblasts in the presence of a semi-
permeable membrane (LPMA+FA ins.), measured by means of MTT, after 72 hours culture in the presence of 2,5 µg/ml conca-
navalin A. Data represent means ± SE of 6 independent experiments.
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[35]. These results confirm the importance of adhesion
molecules for the recruitment and accumulation of
inflammatory cells into the tissues and, most importantly,
suggest their fundamental role in cell-to-cell communica-
tion and inflammation control. Indeed, our findings dem-
onstrate that the adhesion and subsequent interaction
between lymphocytes and fibroblasts have an important
role in down-regulating T cell activation and likely in
dampening the activation state of these cells that charac-
terizes some lung diseases.
With regard to this we have shown that the inhibitory
effect exerted by fibroblasts on T lymphocytes activity is
evident at multiple levels: surface markers expression,
cytokines production and proliferation.
We have shown that the inhibitory effect exerted by
fibroblasts on the expression of LFA-1, CD3, CD28 and
CD69 on lymphocytes is due to a direct interaction since
the inhibitory effect is abolished when a membrane is
placed between fibroblasts and lymphocytes. Considering
that ICAM-1 expression on fibroblasts makes these cells
capable to physically interact with beta 2 integrin positive
inflammatory leukocytes and its expression is increased
by activated lymphocytes, we hypothesized that the
interaction between activated T cells and fibroblasts was
ICAM-1 mediated. Indeed, co-culture experiments
performed preincubating fibroblasts with a neutralizing
anti-ICAM-1 antibody abolished their capacity to reduce
LFA-1, CD28 and CD69 expression on activated
lymphocytes suggesting that a cognate interaction, LFA-1-
ICAM-1 mediated, is requested for the inhibitory effect of
fibroblasts on lymphocytes. Similarly, the inhibitory
effect induced by fibroblasts on T cell CD3 expression has
to be ascribed to a direct interaction, as demonstrated by
the disappearance of the inhibitory activity in the pres-
ence of a membrane physically separating fibroblasts and
lymphocytes. The inhibition of CD3 expression as well as
the simultaneous reduction of LFA-1, CD28, CD69 that
we have described on lymphocytes cultured with fibrob-
lasts may have important effects on the evolution of the
immune response. A full T cell activation depends, in fact,
(i) on the interaction of the T cell receptor (TCR)-CD3
complex with the antigen and (ii) on a second signal
delivered through the costimulatory molecule CD28, nec-
essary for the complete activation [36,37]. The binding of
CD28 and its ligands B7-1 and B7-2 lowers the threshold
number of TCR molecules that need to be engaged to ini-
tiate T cell activation, protects against the induction of T
cell anergy, promotes proliferation, cytokine production
and T cell survival [37,38]. In addition, the interaction
between T cell-mounted LFA-1 and its ligand ICAM-1
functions not only as an adhesive interaction, but may
also deliver a further costimulatory signal able to activate
T cells and is considered important for T cell- antigen pre-
senting cell (APC) interaction [39]. Several data suggest
that these molecules are crucial in the pathogenesis of a
number of lung diseases. Specifically, an influx of
activated T-cells characterizes hypersensitivity
pneumonitis and the blockade of T-cell costimulation
inhibits lung inflammation in a murine model of this dis-
ease [23,40]. In pulmonary sarcodosis, a number of
reports have emphasized the role of pulmonary lym-
phocytes and described phenotypic and functional abnor-
malities of T-cells [22,41] whereas there is evidence
showing that T-lymphocytes may also have a role in the
fibrotic process, although much remains to be defined. In
this regard Okazaky et al. [42] have recently shown that
CD28-mediated T-cell costimulation plays a critical role
in the development of inflammation and fibrosis in bleo-
mycin-treated mice. On the contrary, the administration
of antibodies to LFA-1 leads to a significant reduction in
collagen deposition in lung tissue both in experimental
hypersensitivity pneumonitis [43] and pulmonary fibro-
sis [33]. Furthermore, allergen-induced production of T-
cell derived cytokines in asthma requires the interaction
between costimulatory molecules and points to the
CD28-B7 pathway as being important to the inflamma-
tion distinctive of the disease [44].
To ascertain whether the phenotypical changes above
described were accompanied by a certain degree of
functional alteration we studied cytokine production and
proliferation of co-cultured T lymphocytes.
Specifically we evaluated the production of TNF-alpha
and IL-10 by lymphocytes co-cultured with fibroblasts.
TNF-alpha, is a proinflammatory cytokine with many bio-
logic properties thought to be critical in the development
of pulmonary fibrosis [28]. Whereas, IL-10 is a regulatory
cytokine, that suppresses the production of several proin-
flammatory cytokines [29], likely through the inhibition
of NF-kB activation [45].
According to the immunoregulatory role that we have sug-
gested for fibroblasts, these cells inhibit in T lymphocytes
the production of the proinflammatory cytokine TNF-
alpha whereas the release of the anti-inflammatory
cytokine IL-10 is not affected. Moreover, T-lymphocytes
co-cultured with fibroblasts show a significantly reduced
proliferative response when exposed to a well known
mitogenic stimulus such as concanavalin A [46], underlin-
ing the immunoregulatory role exerted by fibroblasts on
activated t-lymphocytes.
Thus, several lines of evidence indicate that T-lym-
phocytes, through the production of soluble signals and
direct interactions with other cells orchestrate the
immune as well as the inflammatory response and may
consequently be involved in the pathogenesis of severalRespiratory Research 2005, 6:103 http://respiratory-research.com/content/6/1/103
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lung diseases. In this study, we have shown that CD3,
CD28, CD69 and LFA-1, some of the main signals identi-
fying T-cell activation, and taking active part in the
immune response, besides TNF-alpha production, are
down-regulated by human normal lung fibroblasts, affect-
ing the capacity of these cells to proliferate in response to
a non specific stimulus and potentially altering the inter-
action with antigen presenting cells. This study confirms
and expands the concept that tissue resident cells such as
fibroblasts do have a role in the regulation of some
aspects of the immune response acting as a highly effec-
tive local control system of the effector functions of cells
recruited into sites of inflammation. An impairment of
this modulatory attitude can make the difference between
acute self-limited inflammation followed by normal
repair as compared to chronic unquenchable inflamma-
tion leading to loss of tissue architecture and fibrosis.
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